Cargando…

What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review

Hysterectomy is the most common treatment option in women with uterine fibroids, providing definitive relief from the associated burdensome symptoms. As with all surgical interventions, hysterectomy is associated with risk of complications, short-term morbidities, and mortality, all of which have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Madueke-Laveaux, Obianuju Sandra, Elsharoud, Amro, Al-Hendy, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622061/
https://www.ncbi.nlm.nih.gov/pubmed/34830617
http://dx.doi.org/10.3390/jcm10225335
_version_ 1784605605426626560
author Madueke-Laveaux, Obianuju Sandra
Elsharoud, Amro
Al-Hendy, Ayman
author_facet Madueke-Laveaux, Obianuju Sandra
Elsharoud, Amro
Al-Hendy, Ayman
author_sort Madueke-Laveaux, Obianuju Sandra
collection PubMed
description Hysterectomy is the most common treatment option in women with uterine fibroids, providing definitive relief from the associated burdensome symptoms. As with all surgical interventions, hysterectomy is associated with risk of complications, short-term morbidities, and mortality, all of which have been described previously. However, information on the potential long-term risks of hysterectomy is only recently becoming available. A systematic literature review was performed to identify studies published between 2005 and December 2020 evaluating the long-term impact of hysterectomy on patient outcomes. A total of 29 relevant studies were identified. A review of the articles showed that hysterectomy may increase the risk of cardiovascular events, certain cancers, the need for further surgery, early ovarian failure and menopause, depression, and other outcomes. It is important to acknowledge that the available studies examine possible associations and hypotheses rather than causality, and there is a need to establish higher quality studies to truly evaluate the long-term consequences of hysterectomy. However, it is of value to consider these findings when discussing the benefits and risks of all treatment options with patients with uterine fibroids to allow for preference-based choices to be made in a shared decision-making process. This is key to ensuring that patients receive the treatment that best meets their individual needs.
format Online
Article
Text
id pubmed-8622061
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86220612021-11-27 What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review Madueke-Laveaux, Obianuju Sandra Elsharoud, Amro Al-Hendy, Ayman J Clin Med Review Hysterectomy is the most common treatment option in women with uterine fibroids, providing definitive relief from the associated burdensome symptoms. As with all surgical interventions, hysterectomy is associated with risk of complications, short-term morbidities, and mortality, all of which have been described previously. However, information on the potential long-term risks of hysterectomy is only recently becoming available. A systematic literature review was performed to identify studies published between 2005 and December 2020 evaluating the long-term impact of hysterectomy on patient outcomes. A total of 29 relevant studies were identified. A review of the articles showed that hysterectomy may increase the risk of cardiovascular events, certain cancers, the need for further surgery, early ovarian failure and menopause, depression, and other outcomes. It is important to acknowledge that the available studies examine possible associations and hypotheses rather than causality, and there is a need to establish higher quality studies to truly evaluate the long-term consequences of hysterectomy. However, it is of value to consider these findings when discussing the benefits and risks of all treatment options with patients with uterine fibroids to allow for preference-based choices to be made in a shared decision-making process. This is key to ensuring that patients receive the treatment that best meets their individual needs. MDPI 2021-11-16 /pmc/articles/PMC8622061/ /pubmed/34830617 http://dx.doi.org/10.3390/jcm10225335 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Madueke-Laveaux, Obianuju Sandra
Elsharoud, Amro
Al-Hendy, Ayman
What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review
title What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review
title_full What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review
title_fullStr What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review
title_full_unstemmed What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review
title_short What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review
title_sort what we know about the long-term risks of hysterectomy for benign indication—a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622061/
https://www.ncbi.nlm.nih.gov/pubmed/34830617
http://dx.doi.org/10.3390/jcm10225335
work_keys_str_mv AT maduekelaveauxobianujusandra whatweknowaboutthelongtermrisksofhysterectomyforbenignindicationasystematicreview
AT elsharoudamro whatweknowaboutthelongtermrisksofhysterectomyforbenignindicationasystematicreview
AT alhendyayman whatweknowaboutthelongtermrisksofhysterectomyforbenignindicationasystematicreview